GOSSGossamer Bio Inc
GOSS
Gossamer Bio Inc2,923
Mkt Cap
$82.24MVolume
2.84M52W High
$3.8752W Low
$0.32PE Ratio
-0.47GOSS Fundamentals
Price
$0.3339Prev Close
$0.3504Open
$0.357150D MA
$0.4092Beta
2.22Avg. Volume
6.77MEPS (Annual)
-$0.7455P/B
-0.67Rev/Employee
$299,203.70$774.38
Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- Hagens Berman
Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- Hagens Berman Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3...
PR Newswire·1h ago
GOSS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026
GOSS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026 GOSS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Gossamer...
PR Newswire·5h ago
GOSS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Gossamer Bio, Inc. Securities Lawsuit - Contact The Gross Law Firm
GOSS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Gossamer Bio, Inc. Securities Lawsuit - Contact The Gross Law Firm GOSS Shareholder Alert: Investors With Losses May...
PR Newswire·6h ago
GOSS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026
GOSS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026 GOSS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds...
PR Newswire·4d ago
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, April 30, 2026 NEW YORK, April 30, 2026 /PRNewswire/ -- Why:Rosen Law Firm, a global investor rights law...
PR Newswire·5d ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines - GOSS
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines - GOSS INVESTOR ALERT: Pomerantz Law Firm...
PR Newswire·5d ago
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: Hagens Berman
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: Hagens Berman GOSS Investor...
PR Newswire·5d ago
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Misrepresented Patient Enrollment Quality: SueWallSt
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Misrepresented Patient Enrollment Quality: SueWallSt GOSS...
PR Newswire·5d ago
Robbins LLP Urges GOSS Stockholders to Contact the Firm for Information About the Class Action Against Gossamer Bio, Inc.
Robbins LLPreminds stockholders that a class actionwas filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and...
Business Wire·6d ago
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Placebo Response Risks: Levi & Korsinsky
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Placebo Response Risks: Levi & Korsinsky GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class...
PR Newswire·6d ago
<
1
2
...
>